Substantial under-treatment among women diagnosed with osteoporosis in a US managed-care population: a retrospective analysis

American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the Diagnosis and Treatment of Postmenopausal Osteoporosis

(2013) Nelson Watts et al.   Endocrine Practice

Primary non-adherence to bisphosphonates in an integrated healthcare setting

(2013) K. Reynolds et al.   OSTEOPOROSIS INTERNATIONAL

Characteristics associated with anti-osteoporosis medication use: Data from the Global Longitudinal Study of Osteoporosis in Women (GLOW) USA cohort

(2012) Pamela Guggina et al.   BONE

Medication adherence and fracture risk among patients on bisphosphonate therapy in a large United States health plan

(2012) Sally W. Wade et al.   BONE

Burden of non-hip, non-vertebral fractures on quality of life in postmenopausal women

(2012) C. Roux et al.   OSTEOPOROSIS INTERNATIONAL

Non-hip, non-spine fractures drive healthcare utilization following a fracture: the Global Longitudinal Study of Osteoporosis in Women (GLOW)

(2012) G. Ioannidis et al.   OSTEOPOROSIS INTERNATIONAL

Factors associated with treatment of women with osteoporosis or osteopenia from a national survey

(2012) Eric S Meadows et al.   BMC Womens Health

Direct Healthcare Costs of Osteoporosis-Related Fractures in Managed Care Patients Receiving Pharmacological Osteoporosis Therapy

(2012) Hema N. Viswanathan et al.   Applied Health Economics and Health Policy

Regional differences in treatment for osteoporosis. The Global Longitudinal Study of Osteoporosis in Women (GLOW)

(2011) Adolfo Díez-Pérez et al.   BONE

Bone Quality: Educational Tools for Patients, Physicians, and Educators

(2011) Junaid Shams et al.   CLINICAL ORTHOPAEDICS AND RELATED RESEARCH

Effectiveness of interventions to improve the detection and treatment of osteoporosis in primary care settings: a systematic review and meta-analysis

(2011) M.-C. Laliberté et al.   OSTEOPOROSIS INTERNATIONAL

The potential impact of the National Osteoporosis Foundation guidance on treatment eligibility in the USA: an update in NHANES 2005–2008

(2011) B. Dawson-Hughes et al.   OSTEOPOROSIS INTERNATIONAL

Long-Term Effect of the Women's Health Initiative Study on Antiosteoporosis Medication Prescribing

(2010) Euni Lee et al.   JOURNAL OF WOMENS HEALTH

Impact of Prevalent Fractures on Quality of Life: Baseline Results From the Global Longitudinal Study of Osteoporosis in Women

(2010) Jonathan D. Adachi et al.   MAYO CLINIC PROCEEDINGS

Direct and Indirect Costs of Non-Vertebral Fracture Patients with Osteoporosis in the US

(2010) Crystal Pike et al.   PHARMACOECONOMICS

Predictors of oral bisphosphonate prescriptions in post-menopausal women with osteoporosis in a real-world setting in the USA

(2009) C. Asche et al.   OSTEOPOROSIS INTERNATIONAL

Application of the National Osteoporosis Foundation Guidelines to postmenopausal women and men: the Framingham Osteoporosis Study

(2009) S. D. Berry et al.   OSTEOPOROSIS INTERNATIONAL

The Global Longitudinal Study of Osteoporosis in Women (GLOW): rationale and study design

(2009) F. H. Hooven et al.   OSTEOPOROSIS INTERNATIONAL

Excess mortality following hip fracture: a systematic epidemiological review

(2009) B. Abrahamsen et al.   OSTEOPOROSIS INTERNATIONAL

Low rates of treatment in postmenopausal women with a history of low trauma fractures: results of audit in a Fracture Liaison Service

(2009) M.O. Premaor et al.   QJM-AN INTERNATIONAL JOURNAL OF MEDICINE

Undertreatment of osteoporosis following hip fracture in the elderly

(2008) Peter Lüthje et al.   ARCHIVES OF GERONTOLOGY AND GERIATRICS

Osteoporosis Disease Management: The Role of the Orthopaedic Surgeon

(2008) Richard Dell et al.   JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME

Patient Decision to Initiate Therapy for Osteoporosis: The Influence of Knowledge and Beliefs

(2008) Robert A. Yood et al.   JOURNAL OF GENERAL INTERNAL MEDICINE